• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

AJ81:GR

3.265 EUR 0.256 8.51%

As of 13:34:14 ET on 12/19/2014.

Snapshot for Agenus Inc (AJ81)

Open: 3.153 Day's Range: 3.152 - 3.419 Volume: 0
Previous Close: 3.009 52wk Range: 1.714 - 3.950 1-Yr Rtn: +74.88%

Stock Chart for AJ81

No chart data available.
  • AJ81:GR 3.275
  • 1D
  • 1M
  • 1Y
3.009
Interactive AJ81 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for AJ81

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -0.4530
Est. PEG Ratio -
Market Cap (M EUR) 204.66
Shares Outstanding (M) 62.68
30 Day Average Volume 661
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/05/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for AJ81

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for AJ81

Agenus, Inc. develops vaccines. The Company researches vaccines for brain cancer, kidney cancer, herpes, lung cancer, melanoma, malaria, shingles, and Alzheimer's disease.

Garo H ArmenChairman/CEO/Co-FounderRobert B Stein "Bob"Chief Scientific Officer
Ozer BaysalChief Business OfficerKaren H ValentineVP/Chief Compliance Ofcr/Secy
More Company Profile & Key Executives for AJ81

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil